5-β-sapogenin and pseudosapogenin derivatives and...

Details 5-β-sapogenin and pseudosapogenin derivatives and... 5-β-sapogenin and pseudosapogenin derivatives and...

2006-11-21

2006-11-21

Saeed, Kamal A. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S468000, C549S344000, C549S456000

Reexamination Certificate

active

07138427

ABSTRACT:
The invention discloses the use of sapogenin derivatives in the treatment of cognitive disfunction and similar conditions. Methods of treatment and pharmaceutical compositions are also disclosed

REFERENCES:
patent: 3836527 (1974-09-01), Irmscher et al.
patent: 3890438 (1975-06-01), Cayen et al.
patent: 3929769 (1975-12-01), Kaufmann et al.
patent: 3956491 (1976-05-01), Isaac
patent: 4482706 (1984-11-01), Tomimatsu et al.
patent: 4546097 (1985-10-01), Pitha
patent: 4562250 (1985-12-01), Staba et al.
patent: 4602003 (1986-07-01), Malinow
patent: 4602005 (1986-07-01), Malinow
patent: 4680289 (1987-07-01), Applezweig
patent: 4800080 (1989-01-01), Grollier et al.
patent: 5002939 (1991-03-01), Streber
patent: 5017562 (1991-05-01), Holmes et al.
patent: 5244887 (1993-09-01), Straub
patent: 5252729 (1993-10-01), De Crosta et al.
patent: 5589182 (1996-12-01), Tashiro et al.
patent: 5629295 (1997-05-01), Deninno et al.
patent: 5698526 (1997-12-01), Deninno
patent: 5703052 (1997-12-01), Deninno et al.
patent: 5760009 (1998-06-01), Allen et al.
patent: 5763430 (1998-06-01), Zasloff
patent: 5792635 (1998-08-01), Zasloff
patent: 5795885 (1998-08-01), Zasloff et al.
patent: 5804239 (1998-09-01), Wiersma
patent: 5804562 (1998-09-01), Allen et al.
patent: 5807834 (1998-09-01), Morehouse
patent: 5840740 (1998-11-01), Zasloff et al.
patent: 5840936 (1998-11-01), Zasloff et al.
patent: 5847172 (1998-12-01), Zasloff et al.
patent: 5856535 (1999-01-01), Zasloff et al.
patent: 5939398 (1999-08-01), Deninno
patent: 5958770 (1999-09-01), Cham et al.
patent: 6046184 (2000-04-01), Suzuki et al.
patent: 6143738 (2000-11-01), Zasloff
patent: 6150336 (2000-11-01), Deninno et al.
patent: 6258386 (2001-07-01), Xia et al.
patent: 6593301 (2003-07-01), Ma et al.
patent: 6812213 (2004-11-01), Xia et al.
patent: 2001/0024666 (2001-09-01), Waggle et al.
patent: 2001/0026814 (2001-10-01), Waggle et al.
patent: 2001/0029248 (2001-10-01), Waggle et al.
patent: 2001/0043955 (2001-11-01), Xia et al.
patent: 2002/0018811 (2002-02-01), Penteado et al.
patent: 1096031 (1993-05-01), None
patent: 1102186 (1993-10-01), None
patent: 1092991 (1994-10-01), None
patent: 1092992 (1994-10-01), None
patent: 4303214 (1993-02-01), None
patent: 0 054 570 (1982-06-01), None
patent: 1020477 (2000-07-01), None
patent: 1024146 (2000-08-01), None
patent: 2 743 561 (1996-01-01), None
patent: 852847 (1960-11-01), None
patent: 2 097 672 (1982-10-01), None
patent: 2335599 (1999-09-01), None
patent: 2347676 (2000-09-01), None
patent: 62-234025 (1987-10-01), None
patent: 02-188528 (1990-07-01), None
patent: 05-246866 (1993-09-01), None
patent: 09-100295 (1997-04-01), None
patent: WO 92/13873 (1992-08-01), None
patent: WO 94/18994 (1994-01-01), None
patent: WO 94/25017 (1994-11-01), None
patent: WO 95/30341 (1995-11-01), None
patent: WO 96/04296 (1996-02-01), None
patent: WO 97/31933 (1997-09-01), None
patent: WO 98/03180 (1998-01-01), None
patent: WO 98/51302 (1998-11-01), None
patent: WO 98/58543 (1998-12-01), None
patent: WO 98/58650 (1998-12-01), None
patent: WO 99/09837 (1999-03-01), None
patent: WO 99/16449 (1999-04-01), None
patent: WO 99/16786 (1999-04-01), None
patent: WO 99/48482 (1999-09-01), None
patent: WO 99/48507 (1999-09-01), None
patent: WO 00/61153 (2000-10-01), None
patent: WO 01/23406 (2001-04-01), None
patent: WO 01/23407 (2001-04-01), None
patent: WO 01/23408 (2001-04-01), None
patent: WO 01/49703 (2001-07-01), None
Kenney H.E. and Wall M.E., “Steroidal Sapogenins, XLI. Willagenin, a New 12-Keto Sapogenin”, J. Org. Chem., 22:468-469 (1957).
Marker R.E., Wagner R.B., Ulshafer P.R., Wittbecker E.L., Goldsmith D.P.J., and Ruof C.H., “Sterols. CLVII. Sapogenins. LXIX. Isolation and Structures of Thirteen New Steroidal Sapogenins. New Sources for Known Sapogenins.”, J. Am. Chem. Soc., 65:1199-1209 (1943).
Wall M.E. and Serota S., “Steroidal Sapogenins. XLV. Effect of Side Chain Isomerism on Rate of Conversion to Pseudosapogenins”, J. Am. Chem. Soc., 79:6481-6483 (1957).
Farmer SN and Kon GAR, “Sapogenins. Part II. Sarsasapogenin and Smilagenin” Journal of the Chemical Society (1937) pp. 414-420.
Marker RE, Rohrmann E and Jones EM, “Sterols. XCIII. epi-Pseudosarsasapogenin, Pseudosarasapogenine and Pseudochlorogenin” Journal of the American Chemical Society vol. 62, No. 3 (1940) pp. 648-649.
Marker RE, Turner DL, Ulshafer PR, “Sterols. CXLVIII. Sapogenins. LXII. The Structure of the Side Chain in the Dihydro-pseudosapogenins” Journal of the American Chemical Society vol. 64 (1942) pp. 1655-1658.
Marker RE, Wagner RB, Ulshafer PR, Wittbecker EL, Goldsmith DPJ and Ruof CH, “Steroidal Sapogenins” Journal of the American Chemical Society vol. 69, No. 9 (1947) pp. 2167-2230.
Wendler NL, Slates HL and Tishler M, “The transformation of Manogenin to Hecogenin” Journal of the American Chemical Society vol. 74, No. 19 (1952) pp. 4894-4897.
6001 Chemical Abstracts, Columbus, Ohio, US, vol. 49 Oct. 11, 1955 No.21 [full reference: J. Pharm. Soc. Japan 74, 1165-7 (1954)].
Wall ME, Serota S and Eddy CR, “Steroidal Sapogenins. XVII. Sterochemistry of the Spioketal Side Chain” Journal of the American Chemical Society vol. 77 (1955) pp. 2130-1237.
Djerassi C and Fishman J, “Constitution and Stereochemistry of Samogenin, Markogenin and Mexogenin” Journal of the American Chemical Society vol. 77, No. 16 (1955) pp. 4291-4297.
Ziegler JB, Rosen WE and Shabica AC, “The Stereochemistry of Steroidal Sapogenins II” Journal of the American Chemical Society vol. 77, No. 5 (1955) pp. 1223-1229.
Scheer I, Kostic RB and Mosettig E, “The C-25 Isomerism of Smilagenin and Sarsasapogenin” Journal of the American Chemical Society Scheer I, Kostic RB and Mosettig E, “The C-25 Isomerism of Smilagenin and Sarsasapogenin” Journal of the American Chemical Society vol. 77, No. 3 (1955) pp. 641-646.
Elks J, Phillipps GH, Walker T and Wyman LJ, “Studies in the Synthesis of Cortisone. Part XV. Improvements in the Conversion of Hecogenin into 3β : 12β-Diacetoxy-5α: 25D-spirostan-11-one and a Study of the Isomeric 11 : 12-Ketols” Journal of the Chemical Society (Nov. 1956) pp. 4330-4331.
6001 Chemical Abstracts, Columbus, Ohio US, vol. 51 Aug. 25, 1957 No. 16 [full reference: J. Chem. Soc. 1957, 1175-85; cf. C.A. 51,6673f].
Takeda K and Hamamoto K, “The Structure of Metagenin” Tetrahedron Letters No. 3 (1960) pp. 1-8.
6001 Chemical Abstracts, Columbus, Ohio US, vol. 54 Nov. 25, 1960 No. 22 [full reference: Chem. and Pharm. Bull. (Tokyo) 7, 343-8 (1959)].
Hamamoto K, “Steroidal components of domestic plants. XXIV. Structure of metagenin. 4” Chemical and Pharmaceutical Journal (Tokyo) 9 (1961) pp. 32-37.
Pettit GR and Kasturi TR, “Steroids and Related Natural Products. VII. Boron Triflouride Etherate-Lithium Aluminium Hydride Reduction of Smilagenin Acetate” Journal of Organic Chemisty vol. 26 (1961) pp. 4553-4556.
6001 Chemical Abstracts, Columbus, Ohio US, vol. 59 Nov. 25, 1963 No. 11 [full reference: Hua Hsuek Pao 28 (6), 394-7 (1962)].
6001 Chemical Abstracts, Columbus, Ohio US, vol. 59 Sep. 2, 1963 No. 5 [full reference: Chem. and Pharm. Bull. (Tokyo) 11, 139-44 (1963)].
Bedour MS, El-Minajjed D, Fayez MBE and Girgis AN, “Steroid Sapogenins VII. Identification and Origin of 25D-Spirosta-3,5-diene Among the Fenugreek Sapogenins” Journal of Pharmaceutical Sciences vol. 53, No. 10 (1964) pp. 1276-1278.
6001 Chemical Abstracts, Columbus, Ohio US, vol. 63 Dec. 20, 1965 No. 13 [full reference: Chem. and Pharm. Bull. (Tokyo) 11, 95-103 (1963)].
Schreiber K, Ripperger H, and Budzikiewicz H, “(22R:25S)-3β-Amino-5α-spirostan, ein Steroidalkaloid Neuartigen Strukturtyps aus Solanum Paniculatum L.” Tetrahedron Letters No. 45 (1965) pp. 3999-4002.
Schreiber K and Ripperger H, “Jurubine, A Novel Type of Steroidal Saponin with (25S)-3β- amino-5α-furostane-22α.26-diol 0(26

Affiliated with

Also associated with

Rating

5-β-sapogenin and pseudosapogenin derivatives and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-β-sapogenin and pseudosapogenin derivatives and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-β-sapogenin and pseudosapogenin derivatives and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3642464